Navigation Links
A Better Tomorrow Treatment Center Inc., Forterus Inc.'s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
Date:9/10/2008

HUNTINGTON BEACH, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Forterus Inc. (OTC Bulletin Board: FTER) today announced that A Better Tomorrow Treatment Center Inc., its behavioral healthcare subsidiary, is the first in the nation to offer GenRecovery, a DNA-customized program for individuals with a genetic predisposition for addictive behavior.

"As one of the leading addiction treatment centers in California, A Better Tomorrow is constantly striving to improve its success rate with addiction treatment. And one way to do this is to integrate GenRecovery into its recovery programs," said Paul Howarth, CEO of Forterus, Inc.

"GenRecovery could be quite effective in treating individuals whose addictions cannot be treated solely with behavioral-based treatment methods, such as one-one-one counseling, group therapy, cognitive therapy and psychotherapy," said Jerrod Menz, A Better Tomorrow's president, adding that roughly a third of the world's addicts are genetically predisposed to addiction because of genetic causes involving the dysfunction of their dopamine receptors.

"This doesn't mean they will automatically become addicts," Menz continued. "It just means they are more susceptible to addictive behavior than the general population."

Clients who are interested in using GenRecovery (http://www.genrecovery.net) as part of their treatment may have their DNA tested first to determine if they are genetically predisposed to addictive behavior. Customized doses of GenRecovery can then be formulated to meet the patient's specific needs. A Better Tomorrow's GenRecovery program is supported by published studies demonstrating its effectiveness in reducing cravings, stress, and anxiety.

Murrieta, Calif.-based A Better Tomorrow Treatment Center Inc. is accredited by the Commission on Accreditation of Rehabilitation Facilities (CARF), placing it in the top 5 percent of drug and alcohol treatment centers in California.

Forterus, Inc. and its subsidiaries engage in diverse business activities, including thoroughbred breeding and racing, behavioral healthcare and finance. For more information on A Better Tomorrow or Forterus, please visit their respective websites at http://www.abttc.com and http://www.forterus.com.

Application of the Safe Harbor of the Private Securities Litigation Reform Act of 1995: This press release contains, and Forterus may from time to time make, written or oral "forward-looking statements" within the meaning of the U.S. federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and other factors, many of which are outside Forterus's and/or its subsidiaries control that could cause actual results to differ materially from such statements. In particular, statements using words such as "may," "should," "estimate," "expect," "anticipate," "intend," "believe," "predict," "potential," or words of similar import generally involve forward-looking statements.

*These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Paul Howarth

(888) 257-8345

ir@forterus.com


'/>"/>
SOURCE Forterus, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kline Study: Better Brushing Habits Boost European Oral Care Sales
2. Two nanostructures are better than one
3. Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
4. UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
5. DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
6. ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance
7. BASF Podcast - Better Harvest in Spite of Climate Stress
8. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait
9. 2 types of image are better than 1 for analyzing tumors
10. Better Nutrition Launches 2008 Summer Nutrition Tour
11. Better business decisions with real-time data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... MA (PRWEB) , ... December 02, 2016 , ... Robots ... Light Event on December 3rd, 2016. The event, which is held on the ... work with helping Americans with Disabilities back into the workplace. Suitable Technologies is partnering ...
(Date:12/2/2016)... December 2, 2016 The immunohistochemistry (IHC) ... at a CAGR of 7.3% during the forecast period of 2016 ... diagnostic laboratories segment accounted for the largest share of immunohistochemistry (IHC) ... , ... global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies ...
(Date:11/30/2016)... ... November 30, 2016 , ... BEI Kimco, a brand ... a flexure design that ensures high alignment accuracy by preventing unwanted shaft rotation. ... suited where extreme precision is required, such as in medical equipment, laboratory instrumentation, ...
(Date:11/30/2016)... , November 30, 2016 ... a few players hold a dominant share in the ... River Laboratories International, Inc., and Merck KGaA, held a ... 2015. Transparency Market Research observes that these companies are ... on development products that are do not require rabbit ...
Breaking Biology Technology:
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... The report forecasts the biometrics ... a CAGR of 12.28% during the period 2016-2020. ... with inputs from industry experts. The report covers the market landscape ... includes a discussion of the key vendors operating in this market. ...
Breaking Biology News(10 mins):